The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36

Molecular and Cellular Biochemistry

Volumn 239, Issue 1-2, 2002, Pages 193-197

  Febbraio, M L ^a   Guy, E ^a   Coburn, C ^b   Knapp Jr , F F ^c   Beets, A L ^c   Abumrad, N A ^b   Silverstein, R L ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

CD36; CD36 null; Fatty acid translocase; Fatty acid uptake

Indexed keywords

CARRIER PROTEIN; CD36 ANTIGEN; LONG CHAIN FATTY ACID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; FATTY ACID; MEMBRANE PROTEIN; ORGANIC ANION TRANSPORTER;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ATHEROSCLEROSIS; CARDIOMYOPATHY; CELL ADHESION; CELL COMMUNICATION; CELL TRANSPORT; CONTROLLED STUDY; DIABETES MELLITUS; FATTY ACID TRANSPORT; IN VIVO STUDY; INFLAMMATION; LIPID METABOLISM; LIPID TRANSPORT; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; ADIPOCYTE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; METABOLISM;

ANIMALIA;

ADIPOCYTES; ANIMALS; ANTIGENS, CD36; DISEASE MODELS, ANIMAL; FATTY ACIDS; HUMANS; MEMBRANE GLYCOPROTEINS; ORGANIC ANION TRANSPORTERS;

EID: 0036813391     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020515210972     Document Type: Review

References (56)

1. Hamilton JA, Johnson RA, Corkey B: Fatty acid transport: The diffusion mechanism in model and biological membranes. J Mol Neurosci 16: 99-108; discussion 151-157, 2001
2. Hamilton JA, Kamp F: How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? Diabetes 48: 2255-2269, 1999
3. Hamilton JA: Transport of fatty acids across membranes by the diffusion mechanism. Prostagland Leukot Essent Fatty Acids 60: 291-297, 1999
4. Hamilton JA: Fatty acid transport: Difficult or easy? J Lipid Res 39: 467-481, 1998
5. Zakim D: Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Med 212: 5-14, 1996
6. Abumrad NA, Park JH, Park CR: Permeation of long-chain fatty acid into adipocytes. Kinetics, specificity, and evidence for involvement of a membrane protein. J Biol Chem 259: 8945-8953, 1984
7. Abumrad NA, Perkins RC, Park JH: Mechanism of long chain fatty acid permeation in the isolated adipocyte. J Biol Chem 256: 9183-9191, 1981
8. Harmon CM, Abumrad NA: Binding of sulfosuccinimidyl fatty acids to adipocyte membrane proteins: Isolation and amino-terminal sequence of an 88-kD protein implicated in transport of long-chain fatty acids. J Membr Biol 133: 43-49, 1993
9. Abumrad NA, el-Maghrabi MR, Amri EZ: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993
10. Stahl A, Gimeno RE, Tartaglia LA: Fatty acid transport proteins: A current view of a growing family. Trends Endocrinol Metab 12: 266-273, 2001
11. Abumrad N, Coburn C, lbrahimi A: Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. Biochim Biophys Acta 1441: 4-13, 1999
12. Abumrad NA, el-Maghrabi MR, Amri EZ: Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268: 17665-17668, 1993
13. Ibrahimi A, Sfeir Z, Magharaie H: Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport. Proc Natl Acad Sci USA 93: 2646-2651, 1996
14. Ibrahimi A, Bonen A, Blinn WD: Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 274: 26761-26766, 1999
15. Van Nieuwenhoven FA, Verstijnen CP, Abumrad NA: Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Common 207: 747-752, 1995
16. Watanabe K, Ohta Y, Toba K: Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann Nuel Med 12: 261-266, 1998
17. Bonen A, Luiken JJ, Liu S: Palmitate transport and fatty acid transporters in red and white muscles. Am J Physiol 275: E471-478, 1998
18. Bonen A, Dyck DJ, Ibrahimi A: Muscle contractile activity increases fatty acid metabolism and transport and FAT/CD36. Am J Physiol 276: E642-649,1999
19. Coburn CT, Knapp FF Jr, Febbraio M: Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000
20. Fukuchi K, Nozaki S, Yoshizumi T: Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). J Noel Med 40: 239-243, 1999
21. Hajri T, Ibrahimi A, Coburn CT: Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia and myocardial hypertrophy. J Biol Chem 25: 25, 2001
22. Nozaki S, Tanaka T, Yamashita S: CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Coll Biochem 192: 129-135, 1999
23. Pravenec M, Landa V, Zidek V: Transgenic rescue of detective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27: 156-158, 2001
24. Collison M, Glazier AM, Graham D: Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 49: 2222-2226, 2000
25. Febbraio M, Abumrad NA, Hajjar DP: A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062, 1999
26. Watanabe K, Toba K, Ogawa Y: Hypertrophic cardiomyopathy with type I CD36 deficiency. Jpn Circ J 62: 541-542, 1998
27. Tanaka T, Sohmiya K, Kawamura K: Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? J Mol Cell Cardiol 29: 121-127,1997
28. Watanabe K, Ohta Y, Toba K: Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency. Ann Nucl Med 12: 261-266, 1998
29. Gotoda T, Iizuka Y, Yamada N: Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes. Curr Atheroscler Rep 2: 453-454, 2000
30. Miyaoka K, Kuwasako T, Hirano K: CD36 deficiency associated with insulin resistance. Lancet 357: 686-687, 2001
31. Yanai H, Chiba H, Morimoto M: Type I CD36 deficiency in humans is not associated with insulin resistance syndrome. Thromb Haemost 83: 786., 2000
32. Gruarin P, Thorne RF, Dorahy DJ: CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport. Biochem Biophys Res Commun 275: 446-454, 2000
33. Oquendo P, Hundt E, Lawler J: CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58: 95-101, 1989
34. Tao N, Wagner SJ, Lublin DM: CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J Biol Chem 271: 22315-22320, 1996
35. Greenwalt DE, Lipsky RH, Ockenhouse CF: Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine. Blood 80: 1105-1115, 1992
36. Greenwalt DE, Mather IH: Characterization of an apically derived epithelial membrane glycoprotein from bovine milk, which is expressed in capillary endothelia in diverse tissues. J Cell Biol 100: 397-408, 1985
37. Swerlick RA, Lee KH, Wick TM: Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148: 78-83, 1992
38. Ryeom SW, Sparrow JR, Silverstein RL: CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci 109: 387-395, 1996
39. Endemann G, Stanton LW, Madden KS, et al.: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 268: 11811-11816, 1993
40. Ryeom SW, Silverstein RL, Scotto A: Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem 271: 20536-20539, 1996
41. Silverstein RL, Asch AS, Nachman RL: Glycoprotein TV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 84: 546-552, 1989
42. Lisanti MP, Scherer PE, Vidugiriene J: Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Biol 126: 111-126, 1994
43. Dorahy DJ, Lincz LF, Meldrum CJ: Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem J 319: 67-72, 1996
44. Lee H, Woodman SE, Engelman JA: Palmitoylation of caveolin- I at a single site (Cys- 156) controls its coupling to the c-Src tyrosine kinase. J Biol Chem 12: 12, 2001
45. Savill J, Hogg N, Ren Y: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 90: 1513-1522, 1992
46. Dawson DW, Pearce SF, Zhong R: CD36 mediates the in vitro inhibitory effects of thrombospondin-I on endothelial cells. J Cell Biol 138: 707-717, 1997
47. Jimenez B, Volpert OV, Crawford SE: Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48, 2000
48. Sfeir Z, Ibrahimi A, Amri E: Regulation of FAT/CD36 gene expression: Further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids 57: 17-21, 1997
49. Luiken JJ, van Nieuwenhoven FA, America G: Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: Involvement of sarcolemmal proteins. J Lipid Res 38: 745-758, 1997
50. Luiken JJ, Willems J, van der Vusse GJ: Electrostimulation enhances FAT/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes. Am J Physiol Endocrinol Metab 281: E704-712, 2001
51. Binas B, Danneberg H, McWhir J: Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. Faseb J 13: 805-812, 1999
52. Glatz JF, van Nieuwenhoven FA, Luiken JJ: Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 57: 373-378, 1997
53. Aitman TJ, Glazier AM, Wallace CA: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21: 76-83, 1999
54. Pravenec M, Landa V, Zidek V: Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27: 156-158, 2001
55. Knapp FF, Jr., Kropp J, Franken PR: Pharmacokinetics of radio-iodinated fatty acid myocardial imaging agents in animal models and human studies. Quart J Nucl Med 40: 252-269, 1996
56. Li AC, Brown KK, Silvestre MJ: Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531, 2000